Evidence map›Paper›PMID 40130196›Full record

ArticleInternational journal of nanomedicine2025

Cutaneous Evaluation of Fe

Claudia Geanina Watz, Elena-Alina Moacă, Andreea Cioca, Lenuța Maria Șuta, Lavinia Krauss Maldea, Ioana Zinuca Magyari-Pavel, Mirela Nicolov, Ioan-Ovidiu Sîrbu, Felicia Loghin, Cristina A Dehelean

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. FeNanomaterials (Basel, Switzerland) · 2025
    Article
  2. Biological Effects ofPlants (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Claudia Geanina WatzDoctoral School, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.ORCID 0000-0002-2498-4732
Elena-Alina MoacăResearch Center for Pharmaco-Toxicological Evaluation, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.ORCID 0000-0002-2631-7028
Andreea CiocaDepartment of Pathology "Regina Maria" Health Network, Timisoara, 300645, Romania.
Lenuța Maria ȘutaPharmaceutical Technology, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.
Lavinia Krauss MaldeaDepartment of Pharmaceutical Physics, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.
Ioana Zinuca Magyari-PavelDepartment of Pharmacognosy-Phytotherapy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania.
Mirela NicolovDepartment of Pharmaceutical Physics, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.
Ioan-Ovidiu SîrbuDepartment of Biochemistry, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Timisoara, 300041, Romania.
Felicia LoghinDepartment of Toxicology, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy of Cluj-Napoca, Cluj-Napoca, 400012, Romania.
Cristina A DeheleanResearch Center for Pharmaco-Toxicological Evaluation, "Victor Babes" University of Medicine and Pharmacy, Timisoara, 300041, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The high-speed development of nanotechnology industry has fueled a plethora of engineered nanoparticles (NPs) and NP-based consumer products, further leading to massive and uncontrolled human exposure. In this regard, the researches addressing the safety assessment of NPs should be re-approached from the perspective of test parameters variety, closely simulating daily life scenarios. Therefore, the present study adopts complex in vitro models to establish the safety profile of Fe Methods: Advanced 3D human reconstructed epidermal tissues and two different monolayers of immortalized human cells (keratinocytes and fibroblasts), using series of in vitro assays were employed in the current study to evaluate multiple biological responses, as follows: i) divers protocols (skin irritation, phototoxicity assay); ii) different conditions (± UV exposure) and iii) a wide variety of quantification methods, such as: MTT, NR and LDH colorimetric tests - performed to evaluate the viability of the cells/microtissues, respectively, the cytotoxicity of the test compounds. In addition, IL-1α ELISA assay was used to quantify the inflammatory activity induced by the test samples, while immunocytochemistry analysis through fluorescent microscopy was employed to provide insightful information regarding the possible mechanism of action of test samples. Results: The two test samples (S Conclusion: The present results indicate significant differences in toxicity between the two in vitro models under UV conditions, highlighting the importance of model selection and exposure parameters in assessing NP safety. Thus, our findings suggest that Fe

Indexed as

EpidermisMagnetite NanoparticlesCell LineCell SurvivalFibroblastsHumansKeratinocytesUltraviolet RaysMagnetite Nanoparticles1BR33D-microtissuecytotoxicityHaCaTmagnetite NPsUV

Identifiers

PMID40130196
PMCPMC11932040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.